Elevidys

Drug Sarepta Therapeutics, Inc.
Total Payments
$377,981
Transactions
686
Doctors
234
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $375,623 586 187
2023 $2,358 100 86

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $283,428 32 75.0%
Travel and Lodging $43,705 156 11.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,870 7 9.0%
Food and Beverage $16,979 491 4.5%

Top Doctors Receiving Payments for Elevidys — Page 10

Doctor Specialty Location Total Records
, PA-C Medical Wichita, KS $14.74 1
, D.O Pediatrics Sand Springs, OK $14.12 1
, M.D Student in an Organized Health Care Education/Training Program Tulsa, OK $14.11 1
, M.D Student in an Organized Health Care Education/Training Program New Orleans, LA $14.09 1
, M.D Pediatrics Houston, TX $13.87 1
, MD Pediatrics Houston, TX $13.87 1
, PNP Pediatrics Houston, TX $13.87 1
, M.D Pediatrics Houston, TX $13.87 1
, M.D Pediatrics Houston, TX $13.86 1
, PA-C Physician Assistant Gainesville, FL $5.78 1

About Elevidys

Elevidys is a drug associated with $377,981 in payments to 234 healthcare providers, recorded across 686 transactions in the CMS Open Payments database. The primary manufacturer is Sarepta Therapeutics, Inc..

Payment data is available from 2023 to 2024. In 2024, $375,623 was paid across 586 transactions to 187 doctors.

The most common payment nature for Elevidys is "Consulting Fee" ($283,428, 75.0% of total).